Literature DB >> 26031512

Ventricular tachycardias in patients with pulmonary hypertension: an underestimated prevalence? A prospective clinical study.

Dirk Bandorski1, D Erkapic, J Stempfl, R Höltgen, E Grünig, J Schmitt, R Chasan, J Grimminger, T Neumann, C W Hamm, W Seeger, H A Ghofrani, H Gall.   

Abstract

BACKGROUND: Sudden cardiac death (SCD) accounts for approximately 30 % in patients with pulmonary arterial hypertension (PAH). The exact circumference for SCD in this patient population is still unclear. Malignant cardiac arrhythmias are reported to be rarely present. There are no systematic data concerning long-term electrocardiographic (ECG) recording in patients with PAH.
OBJECTIVES: We sought to investigate the rate of potentially relevant arrhythmias in patients with pulmonary hypertension (PH).
METHODS: Consecutive patients without diagnosis of known cardiac arrhythmias followed in our outpatient clinic for PH were enrolled in the study. All patients underwent a 72-h Holter ECG. Clinical data, 6-min walk distance, laboratory values, and echocardiography were collected/performed.
RESULTS: Ninety-two consecutive patients (New York Heart Association class (NYHA) III/IV: 65.2 %/5.4 %, PH Group 1: 35.9 %, Group 3: 10.9 %, Group 4: 28.3 %, Group 5: 2.2 %) were investigated. Relevant arrhythmias were newly detected in 17 patients: non-sustained ventricular tachycardia (n = 12), intermittent second-degree heart block (n = 1), intermittent third-degree heart block (n= 3), and atrial flutter (n = 1). Echocardiographic systolic pulmonary pressure and diameter of the right heart were elevated in patients with relevant arrhythmias. Right heart catheterization revealed higher pulmonary vascular resistance (672 vs. 542 dyn · s · cm(-5), p = 0.247) and lower cardiac index (2.46 vs. 2.82 l/min/m(2), p = 0.184).
CONCLUSIONS: Ventricular tachycardias occur more often in PH patients than previously reported. However, the prognostic relevance of non-sustained ventricular tachycardias in this cohort remains unclear. As a large number of PH patients die from SCD, closer monitoring, e.g., using implantable event recorders, might be useful to identify patients at high risk.

Entities:  

Mesh:

Year:  2015        PMID: 26031512     DOI: 10.1007/s00399-015-0364-8

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  39 in total

1.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

2.  Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography.

Authors:  Lawrence G Rudski; Wyman W Lai; Jonathan Afilalo; Lanqi Hua; Mark D Handschumacher; Krishnaswamy Chandrasekaran; Scott D Solomon; Eric K Louie; Nelson B Schiller
Journal:  J Am Soc Echocardiogr       Date:  2010-07       Impact factor: 5.251

Review 3.  Pulmonary arterial hypertension.

Authors:  Harrison W Farber; Joseph Loscalzo
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

4.  2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

Authors:  Michele Brignole; Angelo Auricchio; Gonzalo Baron-Esquivias; Pierre Bordachar; Giuseppe Boriani; Ole-A Breithardt; John Cleland; Jean-Claude Deharo; Victoria Delgado; Perry M Elliott; Bulent Gorenek; Carsten W Israel; Christophe Leclercq; Cecilia Linde; Lluís Mont; Luigi Padeletti; Richard Sutton; Panos E Vardas
Journal:  Europace       Date:  2013-06-24       Impact factor: 5.214

5.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors: 
Journal:  Eur Heart J       Date:  1996-03       Impact factor: 29.983

6.  Heart rate variability predicts outcome in children with pulmonary arterial hypertension.

Authors:  Astrid E Lammers; Elizabeth Munnery; Alison A Hislop; Sheila G Haworth
Journal:  Int J Cardiol       Date:  2009-01-26       Impact factor: 4.164

7.  Contribution to heart rate variability by mechanoelectric feedback. Stretch of the sinoatrial node reduces heart rate variability.

Authors:  S M Horner; C F Murphy; B Coen; D J Dick; F G Harrison; Z Vespalcova; M J Lab
Journal:  Circulation       Date:  1996-10-01       Impact factor: 29.690

8.  The duration of Holter monitoring in patients with syncope. Is 24 hours enough?

Authors:  E B Bass; E I Curtiss; V C Arena; B H Hanusa; A Cecchetti; M Karpf; W N Kapoor
Journal:  Arch Intern Med       Date:  1990-05

9.  Impact of pulmonary arterial hypertension and its therapy on indices of heart rate variability.

Authors:  Mehmet Mustafa Can; Cihangir Kaymaz; Nartilla Pochi; Tugba Aktimur
Journal:  Med Glas (Zenica)       Date:  2013-08

10.  Ventricular arrhythmias and autonomic profile in patients with primary pulmonary hypertension.

Authors:  A F Folino; F Bobbo; C Schiraldi; F Tona; S Romano; G Buja; F Bellotto
Journal:  Lung       Date:  2003 Nov-Dec       Impact factor: 2.584

View more
  5 in total

1.  Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension.

Authors:  Benjamin Strauss; Yassine Sassi; Carlos Bueno-Beti; Zeki Ilkan; Nour Raad; Marine Cacheux; Malik Bisserier; Irene C Turnbull; Erik Kohlbrenner; Roger J Hajjar; Lahouaria Hadri; Fadi G Akar
Journal:  J Mol Cell Cardiol       Date:  2018-11-28       Impact factor: 5.000

Review 2.  [Arrhythmias in patients with pulmonary hypertension and chronic lung disease].

Authors:  Dirk Bandorski; Reinhard Höltgen; Ardeschir Ghofrani; Viktoria Johnson; Jörn Schmitt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2019-08-22

3.  Irregular wide QRS complex tachycardia in a patient with pulmonary hypertension: What is the mechanism?

Authors:  Abigail Louise D Te; Fa-Po Chung; Yenn-Jiang Lin; Shih-Ann Chen
Journal:  HeartRhythm Case Rep       Date:  2015-10-20

4.  Prognostic Relevance of Nonsustained Ventricular Tachycardia in Patients with Pulmonary Hypertension.

Authors:  Dirk Bandorski; Harilaos Bogossian; Johanna Stempfl; Werner Seeger; Matthias Hecker; Ardeschir Ghofrani; Reinhard Hoeltgen; Henning Gall
Journal:  Biomed Res Int       Date:  2016-12-20       Impact factor: 3.411

Review 5.  Arrhythmic Burden and Outcomes in Pulmonary Arterial Hypertension.

Authors:  Jennifer T Middleton; Angshuman Maulik; Robert Lewis; David G Kiely; Mark Toshner; Athanasios Charalampopoulos; Andreas Kyriacou; Alexander Rothman
Journal:  Front Med (Lausanne)       Date:  2019-07-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.